Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome...
26 insider purchases on record · latest filing 2008-12-10.
Insiders have also filed 6 sale transactions at IVA.